OCT News and Research

RSS

Twenty rising juniors to create bras during summer break

Students at the celebrated Otis College of Art and Design in Los Angeles will contribute decorated bras from the school's design competition for Chesapeake Regional Medical Center's 3rd annual October Bra-ha-ha.

15 May 2010

Xience V sales out-performing Promus in Japanese drug-eluting stent market: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, when Abbott Vascular's Xience V and Boston Scientific's Promus entered the Japanese drug-eluting stent market in Q1 2010, both companies picked up share from competitors Medtronic and Cordis.

6 May 2010

LightLab Imaging granted FDA clearance for C7-XR Imaging System and C7 Dragonfly Imaging Catheter

LightLab Imaging, Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) technology for vascular and other imaging applications, has received clearance from the U.S. Food and Drug Administration (FDA) for the C7-XR Imaging System and companion C7 Dragonfly Imaging Catheter.

5 May 2010

Tomophase receives seventh U.S. Patent for OCTIS component

Tomophase Corporation, a leading developer of non-invasive optical coherence tomography (OCT) tissue imaging devices, announced today that it has received notification of the issuance of its seventh patent: Delivering Light via Optical Waveguide and Multi-view Optical Probe Head, U. S. Patent # 7,706,646.

29 Apr 2010

U.S., other donors commit $880M for new World Bank-hosted Global Food Security fund

The U.S. Treasury Thursday announced $880 million in contributions from the U.S., Canada, Spain, South Korea and the Bill & Melinda Gates Foundation for the new World Bank-hosted Global Agriculture and Food Security Program, Reuters reports (Lawder, 4/22).

24 Apr 2010

Sebelius says HHS will not seek more money this year to implement health overhaul

"The Obama administration does not plan to seek additional money in next year's Health and Human Services Department budget to implement the new U.S. healthcare reform law, HHS Secretary Kathleen Sebelius said on Wednesday," Reuters reports. "Testifying before a House of Representatives Appropriations subcommittee, Sebelius said the $911 billion HHS budget request for fiscal year 2011, which begins Oct. 1, remains the same even after Congress passed the healthcare overhaul," which "included $1 billion" for implementation by HHS.

23 Apr 2010

ThromboGenics microplasmin Phase III program for symptomatic focal VMA meets primary endpoint

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.

20 Apr 2010

Handheld SD-OCT device helps examine vitreoretinal interface in infants with SBS

Ophthalmologists examining infants for possible Shaken Baby Syndrome (SBS) found that a handheld Spectral Domain Optical Coherence Tomography (SD-OCT) device provided high-resolution images of the retina and the vitreoretinal interface in infants with SBS, reports a study in the current issue of Retina, The Journal of Retinal and Vitreous Diseases.

17 Apr 2010

Partners HealthCare offers $40 million to control health insurance costs in Massachusetts; Neb. Gov. signs new abortion law

Partners HealthCare, whose Boston teaching hospitals have been blamed for helping to drive up medical spending, is offering $40 million toward reducing double-digit health insurance rate increases for small businesses, part of a broader package that will be unveiled today by Senate President Therese Murray.

15 Apr 2010

Optovue founds "Eye-Give" non-profit foundation

Optovue, a pioneer in fourier/spectral-domain optical coherence tomography (OCT), has founded "Eye-Give," a non-profit foundation for the purposes of donating technology and funding to sight saving charities and organizations around the world.

13 Apr 2010

OptiMedica releases new details on femtosecond laser system for cataract surgery

OptiMedica Corp., a global ophthalmic device company, has released new details regarding the development of its proprietary femtosecond laser system for cataract surgery. The new system, which combines OptiMedica's breakthrough pattern scanning technology, an ultra-fast laser and integrated Optical Coherence Tomography imaging, is designed to dramatically improve the complex cataract procedure by replacing its most technically demanding and manual steps.

12 Apr 2010

Cancer research at Georgia Tech: Report

Cancer treatment typically involves surgery, radiation therapy, chemotherapy, hormone therapy or biological therapy. An oncologist may use one therapy or a combination of methods, depending on the type and location of the cancer, whether the disease has spread, the patient's age and general health, and other factors.

3 Apr 2010

Physicians face pressures from increased patient loads, looming payment cuts

Two provisions of the new health overhaul law "may accelerate a trend" of doctors leaving their profession. It points to parts of the legislation that would ask physicians to accept new administrative chores and standards, although some of them might result in better reimbursement rates from insurers and the government.

1 Apr 2010

MGH to create registry of patients who had OCT of coronary arteries

Massachusetts General Hospital, together with a coalition of 20 international sites in five countries, will create the world's largest registry of patients who have had optical coherence tomography of the coronary arteries.

26 Mar 2010

ELCA's 49-page draft social statement on genetics

The Evangelical Lutheran Church in America released March 18 a 49-page draft social statement on genetics, a framework for discussion on a variety of current topics in the field including certain advances in medicine, reproductive cloning, human embryonic stem cells, and animal and plant genetic engineering.

20 Mar 2010

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.

12 Mar 2010

Cardiologists to highlight capabilities of InfraReDx' LipiScan Coronary Imaging System at ACC.10 and i2 Summit

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan™ Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology.

11 Mar 2010